about
The role of surfactant in asthmaLPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testingRepeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputumCardiac safety of tiotropium in patients with COPD: a combined analysis of Holter-ECG data from four randomised clinical trials.Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.The effect of titanium dioxide nanoparticles on pulmonary surfactant function and ultrastructure.Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics.Characterization of exhaled particles from the healthy human lung--a systematic analysis in relation to pulmonary function variables.Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPDThe IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.Effect of acute ozone induced airway inflammation on human sympathetic nerve traffic: a randomized, placebo controlled, crossover studyGene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in miceAllergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary diseaseComprehensive characterisation of pulmonary and serum surfactant protein D in COPD.Roflumilast attenuates pulmonary inflammation upon segmental endotoxin challenge in healthy subjects: a randomized placebo-controlled trial.Cell counting in human endobronchial biopsies--disagreement of 2D versus 3D morphometry.Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma.Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study.Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokersCharacterization of exhaled particles from the human lungs in airway obstruction.Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model--a clinical trial.Surfactant Protein D modulates allergen particle uptake and inflammatory response in a human epithelial airway modelConstant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPDEndotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthmaTherapeutic use of surfactant components in allergic asthma.Interaction of nanoparticles with the pulmonary surfactant system.Noninvasive quantification of airway inflammation following segmental allergen challenge with functional MR imaging: a proof of concept study.Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.Quantification of pulmonary inflammation after segmental allergen challenge using turbo-inversion recovery-magnitude magnetic resonance imaging.In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalization.Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein DTiotropium Respimat(®) Versus HandiHaler(®): Comparison of Bronchodilator Efficacy of Various Doses in Clinical TrialsA dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial.The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge.Glutathione improves the function of porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution.
P50
Q24799072-597DBD38-6217-448F-AA32-3692D3882BCCQ28482881-21377EB0-B3AC-4BBF-9BE2-80FABDD80FD9Q28484224-803004B0-8B9E-45AA-9C1C-0FF543B6DC7FQ30877371-143207EA-0F91-4B6F-B5E8-B35E1CFF7171Q33467652-AA762B98-F115-4FC8-93D4-DB8878138F72Q33507731-485DE3CE-6A23-41C5-8C30-B3A0E8D80915Q33557388-C46C2812-F97A-49E0-ABE7-AFB36B8B20AAQ33586460-C918650D-0749-46F4-8204-CD1E972B2E22Q33612752-E58426A2-F789-4763-996B-32AA0A085F47Q33731751-B2A7B8EB-5A80-4DA0-ADB0-9DD68A60DB0AQ33873634-939758D1-4D7E-4B9A-8C57-C44ED25F3803Q34056201-013DF233-A213-451D-96C9-E6AF85073027Q34476656-A2E7BA04-A83B-438B-A858-5FF7A480E028Q34640736-D8ACE9F5-100A-4EE9-822C-E2908D5DFD7EQ34677811-42878039-2D21-4263-8FBF-D00A542BE72AQ34704441-8F7450F6-CAF7-4ABA-BF2C-1325CCA244C2Q34765455-907025D0-8556-4A44-9098-0F75FC3F08DBQ35129318-BC6FF5AC-24BC-4DC2-8807-CF447462AACCQ35138371-73265299-5460-4441-B339-E36E8F16A538Q35161179-8B403FE1-DA81-4855-9F1A-76F70288320BQ35173305-122834A2-B758-4657-9B0F-484235AB9834Q35184631-16BDA4BB-D2FA-4BF9-8EFD-77B42A4A0783Q35743384-6B484B64-0B16-472A-9BA4-F413A0B0E393Q35808861-A6A49387-F507-4BB3-AE52-C08E3DBDB383Q35892456-69E812FA-1A84-4805-8305-3EB2307E1730Q36718646-E0AB28C0-668B-4F20-B97D-B99D541580B3Q37293867-DDE4B998-2331-4659-8C99-159CEC0C82E8Q37532475-ED5E883C-E0D7-4DE8-881F-ADAB080FADE8Q38247340-DE41A92D-6C1B-4490-A131-3144AFA4045BQ38405949-199903F3-56C3-4489-B4C7-E33BDA2F7A36Q38765929-8796C97A-B6B3-4635-AF5A-1C0094A87710Q38945301-85A5829E-BF08-466F-BFC1-CC48BE20F870Q39277279-D3A8F7AC-640F-48D7-BD5A-E7C14A59773FQ39653124-20FEA1FD-EEA4-425E-AB5C-897DCAA0E29EQ39689683-7AC574EB-2BC5-4EF9-B89E-625718E4FBFDQ39846504-3AFC3FDE-C2BF-4F49-9077-A4934BD3CDC5Q39848340-BB59FAB7-AD7D-4053-8C3F-0CFDD32F2AA4Q40209106-2BE02DF8-E007-4278-A6F1-D61BDA292CBAQ40319915-E0363DDA-AF37-4350-896E-07D39BE8EF14Q40390280-FFC74F2B-C7EE-4594-8549-93B3C23C9B02
P50
description
hulumtues
@sq
internist
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jens Hohlfeld
@de
Jens M Hohlfeld
@nl
Jens M Hohlfeld
@sl
Jens M. Hohlfeld
@en
Jens M. Hohlfeld
@es
type
label
Jens Hohlfeld
@de
Jens M Hohlfeld
@nl
Jens M Hohlfeld
@sl
Jens M. Hohlfeld
@en
Jens M. Hohlfeld
@es
prefLabel
Jens Hohlfeld
@de
Jens M Hohlfeld
@nl
Jens M Hohlfeld
@sl
Jens M. Hohlfeld
@en
Jens M. Hohlfeld
@es
P214
P227
P1153
7006477184
P21
P214
P227
P31
P496
0000-0003-2646-6186
P569
1964-10-13T00:00:00Z
P734
P735
P7859
viaf-312632828